Results analysis from Kepler Trust Intelligence
RNS Number : 7220T
Downing Strategic Micro-Cap IT PLC
16 November 2023

Downing Strategic MicroCap (DSM)


Results analysis from Kepler Trust Intelligence

Downing Strategic MicroCap (DSM) has released its half-year financial report for the period ending 31/08/2023. Over the six-month period, the trust saw its NAV decrease by 8.2% on a total return basis, which compares to a 12.8% decrease in the FTSE AIM All-Share Index in the same period.

M&A has continued to feature in the period, with two portfolio companies being taken out in the past six months which has contributed to returns. There is now over 20% of net portfolio assets with agreed bids or under strategic review which should contribute to capital returns.

After a number of years of unrealised potential, and low investor appetite for micro cap stocks, the board has announced a planned wind down. The board have decided a journey towards a full redemption will be the best way of unlocking value in the trust. The first return to shareholders of at least 20% of the portfolio is expected to come in early 2024.

Chairman Hugh Aldous said, "Most of DSM's portfolio is performing well and more is ripe for M&A or rerating", but despite this ongoing uncertainty means he "has concluded that it would advantage all shareholders equally and fairly to commence a managed wind down of the company's investment portfolio in an orderly manner".

Kepler View

Managers Judith Mackenzie and Nick Hawthorn have released, in our opinion, a bittersweet half-yearly annual report for Downing Strategic MicroCap (DSM). On the one hand, they have delivered another period of outperformance from their concentrated portfolio of companies at the smallest end of the market cap spectrum. However, they also acknowledge the ongoing headwinds towards the sector mean that the prospects for their holdings are unlikely to be fulfilled in the foreseeable future. As such, they believe shareholders will be best served by a winding up of the trust and a returning of capital to shareholders.

Judith and Nick highlight that two holdings received bids in the period and another has announced a strategic review. We understand these will likely make up the first capital repayment of c. 20%. Before the announcement, the shares traded at a 17.8% discount to NAV. We believe this approach of selling the 'low-hanging fruit' should offer investors a near-term boost of a well-defined capital return in the interim, at a price that is likely to be much closer to NAV than the shares currently trade at, with the potential for future returns as the wind down process continues.

The managers also highlight positive performance from a number of holdings including one the managers had recently added to and another DSM helped appoint a new director. We believe this demonstrates the potential in the portfolio which could contribute to further returns going forward, though this will be primarily led by exit values achieved.

Going forward, we believe this means the discount could be seen as attractive. While it will take some time to wind up the portfolio, and markets could move in the interim, there is the scope for periodic distributions at or near NAV. Furthermore, there is still potential for the managers to deliver value through their active approach. It may take some time to fully realise the value, as the UK remains out of favour, but this wind down approach could deliver strong returns if the managers achieve exits close to the current value in the NAV.


Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP.  The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.  

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.


Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.


This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.